£520.00

The 2023-2028 Outlook for Diabetic Gastroparesis Treatments in the United States

Price data last checked 78 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 13 days • 13 data points (No recent data available)

Historical
Generating forecast...
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 26 January 2026 29 January 2026 01 February 2026 04 February 2026 07 February 2026

Price Distribution

Price distribution over 13 days • 1 price levels

Days at Price
13 days 0 3 7 10 13 £520 Days at Price

Price Analysis

Most common price: £520 (13 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 13 days

Product Specifications
Format
Paperback
ASIN
B0BLR1QXW2
Category
Books > Subjects
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
09 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for Diabetes Treatments in the United States
98% match

The 2023-2028 Outlook for Diabetes Treatments in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Diabetic Ulcer Treatments in the United States
98% match

The 2023-2028 Outlook for Diabetic Ulcer Treatments in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Diabetic Gastroparesis Treatments for US Zip Codes
97% match

The 2023-2028 Outlook for Diabetic Gastroparesis Treatments for US Zip Codes

£490.00 21 Feb 2026
The 2023-2028 Outlook for Diabetic Ulcers in the United States
97% match

The 2023-2028 Outlook for Diabetic Ulcers in the United States

£520.00 23 Jan 2026
The 2023-2028 Outlook for Diabetic Nephropathy Treatments in the United States
97% match

The 2023-2028 Outlook for Diabetic Nephropathy Treatments in the United States

£520.00 24 Jan 2026
The 2023-2028 Outlook for Diabetic Neuropathy in the United States
97% match

The 2023-2028 Outlook for Diabetic Neuropathy in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Diabetes Drugs in the United States
97% match

The 2023-2028 Outlook for Diabetes Drugs in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in the United States
97% match

The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in the United States

£520.00 28 Jan 2026
The 2023-2028 Outlook for Diabetes Care Products in the United States
97% match

The 2023-2028 Outlook for Diabetes Care Products in the United States

£520.00 28 Jan 2026
The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in the United States
97% match

The 2023-2028 Outlook for Exocrine Pancreatic Insufficiency Therapeutics in the United States

£520.00 03 Feb 2026
The 2023-2028 Outlook for Sarcopenia Treatments in the United States
97% match

The 2023-2028 Outlook for Sarcopenia Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Enteric Disease Testing-Treatment in the United States
97% match

The 2023-2028 Outlook for Enteric Disease Testing-Treatment in the United States

£520.00 27 Jan 2026
The 2023-2028 Outlook for Diabetic Foot Ulcer Therapeutics in the United States
97% match

The 2023-2028 Outlook for Diabetic Foot Ulcer Therapeutics in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Obesity Treatments in the United States
97% match

The 2023-2028 Outlook for Obesity Treatments in the United States

£520.00 23 Mar 2026
The 2023-2028 Outlook for Dysphagia Management Drugs in the United States
96% match

The 2023-2028 Outlook for Dysphagia Management Drugs in the United States

£520.00 01 Mar 2026
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States
96% match

The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Motion Sickness Treatments in the United States
96% match

The 2023-2028 Outlook for Motion Sickness Treatments in the United States

£520.00 31 Jan 2026
The 2023-2028 Outlook for Enzyme Replacement Therapy for Gaucher Diseases in the United States
96% match

The 2023-2028 Outlook for Enzyme Replacement Therapy for Gaucher Diseases in the United States

£520.00 18 Feb 2026
The 2023-2028 Outlook for Digestive Health Food and Drinks in the United States
96% match

The 2023-2028 Outlook for Digestive Health Food and Drinks in the United States

£520.00 01 Feb 2026
The 2023-2028 Outlook for Traveler's Diarrhea Therapeutics in the United States
96% match

The 2023-2028 Outlook for Traveler's Diarrhea Therapeutics in the United States

£520.00 26 Jan 2026
The 2023-2028 Outlook for Diabetes Diagnostic Test Strips in the United States
96% match

The 2023-2028 Outlook for Diabetes Diagnostic Test Strips in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Peptides and Heparin for Diabetes in the United States
96% match

The 2023-2028 Outlook for Peptides and Heparin for Diabetes in the United States

£520.00 01 Feb 2026
The 2023-2028 Outlook for Traveler's Diarrhea Treatments in the United States
96% match

The 2023-2028 Outlook for Traveler's Diarrhea Treatments in the United States

£520.00 26 Jan 2026
The 2023-2028 Outlook for Optic Nerve Disorders Treatments in the United States
96% match

The 2023-2028 Outlook for Optic Nerve Disorders Treatments in the United States

£520.00 14 Jan 2026